Human c-Met L-ELISA (soluble) quantifies c-Met Hu in serum, plasma, and human cell culture supernatant. The dosage will recognize only the natural and recombinant human c-Met. Principle of the L-ELISA sandwich method...
Human c-Met L-ELISA (soluble) quantifies c-Met Hu in serum, plasma, and human cell culture supernatant. The dosage will recognize only the natural and recombinant human c-Met. The principle of the L-ELISA solid phase sandwich method for human c-Met (immuno-enzymatic test) is designed to measure the amount of the target bound between a pair of matched antibodies. A target-specific antibody was pre-vested in the wells of the supplied microplate. Samples, standards or controls are then added to these wells and bound to immobilized antibody (capture). The sandwich is formed by adding the second antibody (detector), a substrate solution that reacts with the enzyme-antibodies-target complex to produce a measurable signal. The intensity of this coloured product is directly proportional to the concentration of TP (p) present in the original sample. Rigorous validation Each batch manufactured from this ELISA kit is tested for quality for criteria such as sensitivity, specificity, accuracy and batch-to-batch consistency. See the product manual for more information on validation.
The hepatocyte growth factor receptor (HGF R), a proto-oncogen c-Met product, is a heterodimeric transmembrane glycoprotein that is a receptor-type tyrosine kinase. The c-Met heterodimer is composed of an alpha chain that is bound to disulfide to a beta chain. Each alpha and beta subunit heterodimer contains 1152 amino acid residues of a calculated molecular mass of approximately 129 kDa. The alpha chain is exposed to the cell surface and the beta chain extends over the plasma membrane. C-Met is synthesized as a single-chain precursor that undergoes co-translational glycosylation and proteolytic cleavage producing the heterodimeric maturity form. Human and mouse HGF receptors have 89% amino acid identity. HGF is the ligand of the HGF receptor.
Measurement range
Dose range: 0.78-50 ng/ml.
Duration of dosing
Total duration of dosing: 4 hours.
Reproducibility
Coefficient of intra-dose variation 6.1%, inter-dose 8.1%.
Samples
Sample type: Serum, Surnatant, Surnatant (plasma volume, 5 μl; serum, 5 μl; supernatant, 50 μl).
Technical specifications
| General |
| Brand | Invitrogen |
| Supplier ref. (Fisher Scientific) | 10402355 |
| Specifications |
| Accession number | P08581 |
| Dose range | 0.78-50 ng/ml |
| Sensitivity of the dosage | <0.5 ng |
| Conjugate | HRP |
| Product type | Kit ELISA |
| Type of sample | Serum, Surnatant, Surnatant |
| Target species | Human |
| For use with (application) | Colorimetric detection |
| For use with (equipment) | Colorimetric microplate reader |
| Genetic identification (Enter) | 4233 |
| Gene symbol(s) | AUTS9,DFNB97,HGFR,RCCP2,c-Met |
| Incubation time | 4 h |
| Coefficient of inter-dose variation | 8.1% |
| Coefficient of intra-dose variation | 6.1% |
| Contents of kits | 96-well pre-coated plate, Standard dilution stamp, Standard dilution stamp, Antibodies detection, Anti-RPH, HRP diluent, Wash pad, Chromogen, Stop solution, Adhesive plate covers |
| Marker or dye | HRP |
| Genetic marker | c-Met (soluble) |
| Quantity | 96 tests |
| Regulatory status | RUO |
| Target | Human |
| Test time | 1 h 20 min |
| Physical characteristics |
| Volume of sample | Plasma, 5 μl; serum, 5 μl; supernatant, 50 μl |
| Storage and shipping |
| Storage conditions | 2°C to 8°C |
| Total duration of dosing | 4 h |
Origin and customs
| Manufacturer ref. | KHO2031 |
|---|
| Country of origin | Autriche |
|---|
| HS customs code | 3002 15 00 00 |
|---|
A question or a specific configuration?
Contact us for a quote.